John CijiangHe Icahn School of Medicine at Mount SinaiUnited States

John CijiangHe
Dr. John Cijiang He is Professor of Medicine and Pharmacological Sciences at Icahn School of Medicine at Mount Sinai. He holds the title of Irene and Dr. Arthur M. Fishberg endowed chair of Nephrology. He is the division chief of Nephrology at Mount Sinai Health System. He is a member of the American Society of Clinical Investigation and American Association of Physicians. His research interest has been in the field of glomerular cell biology and pathogenesis of glomerular disease by focusing on diabetic kidney disease and viral nephropathy. His lab uses systems biology approach to identify potential new biomarkers and drug targets for diabetic kidney disease and viral kidney disease. He has published more than 250 peer-reviewed papers in these areas.
Institution

Day 2 - Monday April 15, 2024

Time Session
4:30 p.m.
5:30 p.m.
Designing Smart Clinical Trials
DebbieGipson Chairperson debbie.gipson@nih.govNational Institutes of Health/NIDDKUnited States
JonathanBarratt Chairperson University of Leicester, Leicester, UKUnited Kingdom
  • Patients Subphenotyping: The Example of Diabetic Kidney Disease
    John CijiangHe Speaker cijiang.he@mssm.eduIcahn School of Medicine at Mount SinaiUnited States
  • Power of AI to Develop Data-driven Early Detection, Diagnosis, and Management of Kidney Disease
    LauraMariani Speaker University of MichiganUnited States
  • Targeted Approaches in Clinical Trial Design
    HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands
  • Q and A
Hall D